• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE-TEX® STRETCH VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number ST0804
Device Problems Partial Blockage (1065); No Apparent Adverse Event (3189)
Patient Problem Stenosis (2263)
Event Date 10/21/2021
Event Type  Injury  
Manufacturer Narrative
H6-b14 and c19: a review of the manufacturing records.[manufacturing/boxing/sterilization/packaging] indicated the lot met all pre-release specifications.H6-b20 and h3-other: the device remains implanted in the patient.Therefore a device evaluation could not be performed.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
Reportedly on (b)(6) 2016, the patient underwent surgical treatment with a gore-tex® stretch vascular graft to treat an occlusive peripheral arterial disease.The procedure was completed without any complications.Reportedly on (b)(6) 2016, an adverse event termed "stenosis of the right femoral bifurcation" was discovered, the primary relationship was recorded as procedure related.A reintervention (not further specified) was performed and the patient recovered without a sequelae.
 
Event Description
Reportedly on (b)(6) 2016, the patient underwent surgical treatment with a gore-tex® stretch vascular graft to treat an occlusive peripheral arterial disease of the right leg.The proximal anastomosis was at the right prosthetic branch of a previously implanted aorto-bifemoral bypass (not specified), the distal anastomosis was above the knee at the femoral artery.The procedure was completed without any complications.Reportedly on (b)(6) 2016, an adverse event termed "stenosis of the right femoral bifurcation" was discovered, the primary relationship was recorded as procedure related.The site study coordinator stated that the gore-tex® stretch vascular graft was not stenosed, the right common femoral artery was stenosed instead.An excision of the right common femoral artery was performed and the gore-tex® stretch vascular graft was prolonged with another gore-tex® graft (not further specified).The patient recovered without sequelae.
 
Manufacturer Narrative
B5: updated event description cause investigation and conclusion: rationale for why the event is considered not reportable: this complaint was initiated based on information received from an automated alert of a retrospective study on (b)(6) 2023.The database entries were reviewed and the provided information was captured in sections 2 and 3.Several requests were sent to the study site to further clarify the event, on (b)(6) 2023, additional information to the event was provided by the study site.The provided information was captured in the updated event description.A review of the manufacturing records indicated the lot met all pre-release specifications.Neither images enabling direct assessment of product performance nor the product itself, which remains implanted, were returned for evaluation.The cause of the reported stenosis of the native common femoral artery remains unknown.From the description of the incident, it appears that the gore-tex® stretch vascular graft was not affected by the stenosis.Therefore the available information does not reasonably suggest a potential malfunction has occurred.No allegation of device malfunction was indicated with respect to device performance.The description of the incident therefore no longer meets the criteria of a reportable incident.The incident description no longer meets the criteria of a reportable incident and therefore it was retracted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE-TEX® STRETCH VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WEST B/P
1505 n. fourth street
flagstaff AZ 86004
Manufacturer Contact
sibylle staerk
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key17581218
MDR Text Key321519086
Report Number2017233-2023-04215
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132612734
UDI-Public00733132612734
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K933943
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/20/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/23/2021
Device Catalogue NumberST0804
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/20/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/24/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age51 YR
Patient SexFemale
-
-